Related Experiment Video
Updated: Jul 10, 2026

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?
Gian Paolo Rossi1, Teresa Maria Seccia, Achille Cesare Pessina
1Department of Clinical and Experimental Medicine (DMCS-Internal Medicine 4), School of Medicine, University of Padua, Padua, Italy. gianpaolo.rossi@unipd.it
Insights
High plasma homocysteine (tHcy) levels predict cardiovascular death in hypertensive patients. This finding, linked to reduced left ventricular function, suggests potential benefits of tHcy-lowering treatments in coronary artery disease.
Area of Science:
- Cardiology
- Biochemistry
- Clinical Research
Background:
- Plasma total homocysteine (tHcy) is implicated in coronary artery disease (CAD).
- Previous studies suggest a link between tHcy and cardiovascular outcomes.
- The precise role of tHcy in hypertensive patients with CAD requires further elucidation.
Purpose of the Study:
- To investigate the association between tHcy levels and cardiovascular mortality in hypertensive patients with CAD.
- To explore the relationship between tHcy and left ventricular (LV) function.
- To determine if tHcy impacts cardiovascular risk independently of established CAD markers.
Main Methods:
- Analysis of data from the GENICA (Genetic and Environmental factors In Coronary Atherosclerosis) study.
- Assessment of tHcy levels in relation to cardiovascular mortality and LV ejection fraction.
- Statistical analysis to control for confounding factors like CAD severity and history of myocardial infarction.
Main Results:
- High tHcy levels were a significant predictor of cardiovascular mortality in hypertensive patients, independent of CAD and myocardial infarction history.
- tHcy was not associated with the extent of coronary atherosclerosis.
- An inverse relationship was observed between tHcy levels and left ventricular ejection fraction, indicating impaired systolic function.
Conclusions:
- Elevated tHcy is an independent risk factor for cardiovascular mortality in hypertensive CAD patients.
- The inverse association between tHcy and LV function may explain its link to heart failure risk.
- Further research into tHcy's effect on LV function is warranted to explore therapeutic strategies for CAD.
Abstract:
Experimental and observational studies support a role of plasma homocysteine levels (tHcy) in coronary artery disease (CAD). In the GENICA (Genetic and Environmental factors In Coronary Atherosclerosis) study, we found that high tHcy predicted cardiovascular mortality in hypertensive, but not in normotensive, patients independently of CAD and history of myocardial infarction. Moreover, despite not being associated with the coronary atherosclerotic burden, tHcy was inversely associated with left ventricular (LV) ejection fraction. This inverse relationship between LV systolic function and tHcy, which has been independently confirmed, might explain the association of tHcy with the risk of incident heart failure documented in the Framingham Heart Study. Thus, additional mechanistic investigation taking into consideration the effects of tHcy on LV function is necessary to further explore the potential therapeutic usefulness of tHcy lowering treatment in CAD.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease III: Clinical Manifestations